DEM BioPharma
Cambridge, US · 8 known investors
DEM BioPharma is a biotechnology company developing cancer therapies by targeting the immune system, drawing on genetic and immuno-oncology research. The company applies discovery approaches based on academic work in genetics and cancer biology.
Founders & leadership
NG
Nenad GrmusainChief Executive Officer
JM
John McCabeChief Financial and Operating Officer
Investors · 8
In the news
Frequently asked questions
- What does DEM BioPharma do?
- DEM BioPharma is a biotechnology company developing cancer therapies by targeting the immune system, drawing on genetic and immuno-oncology research. The company applies discovery approaches based on academic work in genetics and cancer biology.
- Who are DEM BioPharma's investors?
- DEM BioPharma's investors include Alta Partners, Astellas Venture Management LLC, DC Investment Partners, Longwood Fund, Pfizer Venture Investments, UTokyo Innovation Platform Co. Ltd., Insight Partners, Pfizer Ventures.
- Where is DEM BioPharma headquartered?
- DEM BioPharma is headquartered in Cambridge, US.